National hematology institute expands stem cell collection services
The Hanoi-based National Institute of Hematology and Blood Transfusion (NTHBT) had stored more than 5,500 umbilical cord blood units in its stem cell bank as of June 2022, many of which have been used in life-saving transplants for people with serious diseases.
Hanoi (VNA) – The Hanoi-based National Institute of Hematology and Blood Transfusion (NTHBT) had stored more than 5,500 umbilical cord blood units in its stem cell bank as of June 2022, many of which have been used in life-saving transplants for people with serious diseases.
Opened in April 2012, the bank is the top facility in Vietnam in extracting, storing, testing and multiplying stem cells extracted from cord blood samples. It is known for top-notch equipment and a team of skilled medical staff who have been trained on stem cell preservation in the world’s leading institutions.
More and more parents want to preserve stem cells extracted from their newborns’ cord blood. Most of the stem cell banks are in major cities, like Hanoi and Ho Chi Minh City, so non-resident expecting mothers normally had to travel far to use this service.
To meet the rising demand, the bank has launched a new service in which its staff can travel outside the capital city to collect cord blood samples of newborns.
The service is now available in the northern and northern central provinces, including Hai Duong, Hung Yen, Thai Binh, Nam Dinh, Bac Binh, Bac Giang, Vinh Phuc, Thai Nguyen, Quang Ninh, Thanh Hoa and Nghe An.
The bank has established cooperation with hospitals in Hai Phong and Phu Tho where cord blood units can be collected by trained medical workers of the hospitals before they are sent to the bank for processing and storing.
♛ It plans to develop partnerships with more hospitals outside Hanoi to scale up this type of services in the region./.
Vietnam has become one of the pioneers in the world in research and application of stem cell therapy to treat autism spectrum disorder (ASD) following new findings of the research body of Vinmec, a member of VinGroup.
The Children’s Hospital 2 in Ho Chi Minh City has successfully performed an autologous stem cell transplant on the smallest patient so far - a 32-month-old girl suffering from severe neuroblastoma (NB).
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustration. (Photo: vienhuyethoc.vn)
